26.08.2010
- Sanofi-Aventis shareholders L'oreal and Total worry that the French drugmaker will pay too much for U.S. biotech company Genzyme and are not convinced it is the best fit, bankers...
04.08.2010
- Sanofi-Aventis has grabbed the headlines with its $18.4 billion bid for Genzyme, but the French drugmaker may be wiser to stick with smaller, bolt-on acquisitions. Sanofi is trying...
